BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29611113)

  • 1. Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects.
    Sohail M; Mudassir ; Minhas MU; Khan S; Hussain Z; de Matas M; Shah SA; Khan S; Kousar M; Ullah K
    Drug Deliv Transl Res; 2019 Apr; 9(2):595-614. PubMed ID: 29611113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel biodegradable pH-sensitive hydrogels: An efficient controlled release system to manage ulcerative colitis.
    Abbasi M; Sohail M; Minhas MU; Khan S; Hussain Z; Mahmood A; Shah SA; Kousar M
    Int J Biol Macromol; 2019 Sep; 136():83-96. PubMed ID: 31195039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
    Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M
    Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapy.
    You YC; Dong LY; Dong K; Xu W; Yan Y; Zhang L; Wang K; Xing FJ
    Carbohydr Polym; 2015 Oct; 130():243-53. PubMed ID: 26076623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multistage-Responsive Nanocomplexes Attenuate Ulcerative Colitis by Improving the Accumulation and Distribution of Oral Nucleic Acid Drugs in the Colon.
    Li X; Yang Y; Wang Z; Ju H; Fu X; Zou L; Li M; Xue Q; Ma H; Meng Y; Zhao L; Qi H; Yu T
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):2058-2070. PubMed ID: 34978415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Assembled Polymers for Gastrointestinal Tract Targeted Delivery through the Oral Route: An Update.
    Yang X; Yang Y; Yu H; Zhou Y
    Polymers (Basel); 2023 Aug; 15(17):. PubMed ID: 37688164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice.
    Bai XY; Yan Y; Wang L; Zhao LG; Wang K
    Drug Deliv; 2016 Jul; 23(6):1926-32. PubMed ID: 25693641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives.
    Chen M; Lan H; Jin K; Chen Y
    Drug Deliv; 2023 Dec; 30(1):2219427. PubMed ID: 37288799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydrogel drug delivery system for treating ulcerative colitis: A preclinical meta-analysis.
    Jiang L; Li J; Yang R; Chen S; Wu Y; Jin Y; Wang J; Weng Q; Wang J
    Int J Pharm; 2024 Jun; 659():124281. PubMed ID: 38802026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
    Gugulothu D; Kulkarni A; Patravale V; Dandekar P
    J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
    Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
    Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and synthetic biomaterials for controlled drug delivery.
    Kim JK; Kim HJ; Chung JY; Lee JH; Young SB; Kim YH
    Arch Pharm Res; 2014 Jan; 37(1):60-8. PubMed ID: 24197492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable hydrogels for sustained release of therapeutic agents.
    Thambi T; Li Y; Lee DS
    J Control Release; 2017 Dec; 267():57-66. PubMed ID: 28827094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review on Magnetic Natural Polymer Constructed Hydrogels as Vehicles for Drug Delivery.
    Liao J; Huang H
    Biomacromolecules; 2020 Jul; 21(7):2574-2594. PubMed ID: 32543834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomaterials in treatment of Alzheimer's disease.
    Agrawal M; Prathyusha E; Ahmed H; Dubey SK; Kesharwani P; Singhvi G; Naidu VGM; Alexander A
    Neurochem Int; 2021 May; 145():105008. PubMed ID: 33684545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
    Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
    Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
    Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis.
    Courthion H; Mugnier T; Rousseaux C; Möller M; Gurny R; Gabriel D
    J Control Release; 2018 Apr; 275():32-39. PubMed ID: 28774843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.